| Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy JP Pezacki, JA Blake, DC Danielson, DC Kennedy, RK Lyn, ... Nature chemical biology 7 (3), 137-145, 2011 | 257 | 2011 |
| microRNA-33 regulates macrophage autophagy in atherosclerosis M Ouimet, H Ediriweera, MS Afonso, B Ramkhelawon, R Singaravelu, ... Arteriosclerosis, Thrombosis, and Vascular Biology 37 (6), 1058-1067, 2017 | 201 | 2017 |
| Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti-miR33 in atherosclerosis D Karunakaran, AB Thrush, MA Nguyen, L Richards, M Geoffrion, ... Circulation research 117 (3), 266-278, 2015 | 187 | 2015 |
| Hepatitis C virus induced up‐regulation of microRNA‐27: A novel mechanism for hepatic steatosis R Singaravelu, R Chen, RK Lyn, DM Jones, S O'Hara, Y Rouleau, ... Hepatology 59 (1), 98-108, 2014 | 120 | 2014 |
| Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes RK Lyn, R Singaravelu, S Kargman, S O'Hara, H Chan, R Oballa, ... Scientific Reports 4 (1), 4549, 2014 | 73 | 2014 |
| MicroRNAs regulate the immunometabolic response to viral infection in the liver R Singaravelu, S O'hara, DM Jones, R Chen, NG Taylor, P Srinivasan, ... Nature chemical biology 11 (12), 988-993, 2015 | 71 | 2015 |
| Competing roles of microRNA-122 recognition elements in hepatitis C virus RNA N Nasheri, R Singaravelu, M Goodmurphy, RK Lyn, JP Pezacki Virology 410 (2), 336-344, 2011 | 57 | 2011 |
| An enzyme-linked assay for the rapid quantification of microRNAs based on the viral suppressor of RNA silencing protein p19 N Nasheri, J Cheng, R Singaravelu, P Wu, MT McDermott, JP Pezacki Analytical biochemistry 412 (2), 165-172, 2011 | 54 | 2011 |
| Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe R Singaravelu, DR Blais, CS McKay, JP Pezacki Proteome science 8, 1-15, 2010 | 47 | 2010 |
| Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy ME Wedge, VA Jennings, MJF Crupi, J Poutou, T Jamieson, A Pelin, ... Nature communications 13 (1), 1898, 2022 | 38 | 2022 |
| Characterization of critical determinants of ACE2–SARS CoV-2 RBD interaction EEF Brown, R Rezaei, TR Jamieson, J Dave, NT Martin, R Singaravelu, ... International Journal of Molecular Sciences 22 (5), 2268, 2021 | 37 | 2021 |
| Hepatitis C virus and microRNAs: miRed in a host of possibilities R Singaravelu, RS Russell, DL Tyrrell, JP Pezacki Current opinion in virology 7, 1-10, 2014 | 37 | 2014 |
| Fluorescence lifetime imaging of alterations to cellular metabolism by domain 2 of the hepatitis C virus core protein N Mazumder, RK Lyn, R Singaravelu, A Ridsdale, DJ Moffatt, CW Hu, ... PLoS one 8 (6), e66738, 2013 | 35 | 2013 |
| Host–virus interactions during hepatitis C virus infection: a complex and dynamic molecular biosystem JP Pezacki, R Singaravelu, RK Lyn Molecular BioSystems 6 (7), 1131-1142, 2010 | 34 | 2010 |
| MicroRNA-7 mediates cross-talk between metabolic signaling pathways in the liver R Singaravelu, C Quan, MH Powdrill, TA Shaw, P Srinivasan, RK Lyn, ... Scientific Reports 8 (1), 361, 2018 | 32 | 2018 |
| Concise review: targeting cancer stem cells and their supporting niche using oncolytic viruses MJF Crupi, JC Bell, R Singaravelu Stem Cells 37 (6), 716-723, 2019 | 31 | 2019 |
| Human serum activates CIDEB-mediated lipid droplet enlargement in hepatoma cells R Singaravelu, RK Lyn, P Srinivasan, J Delcorde, RH Steenbergen, ... Biochemical and Biophysical Research Communications 441 (2), 447-452, 2013 | 31 | 2013 |
| SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition T Azad, R Singaravelu, EEF Fekete, Z Taha, R Rezaei, R Arulanandam, ... Biosensors and Bioelectronics 180, 113122, 2021 | 30 | 2021 |
| Deletion of apoptosis inhibitor F1L in vaccinia virus increases safety and oncolysis for cancer therapy A Pelin, J Foloppe, J Petryk, R Singaravelu, M Hussein, F Gossart, ... Molecular Therapy-Oncolytics 14, 246-252, 2019 | 30 | 2019 |
| Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry T Azad, R Singaravelu, Z Taha, TR Jamieson, S Boulton, MJF Crupi, ... Molecular Therapy 29 (6), 1984-2000, 2021 | 28 | 2021 |
